Logos Global Management LP

SAN FRANCISCO, CA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$1.65B2026 Q3+ $201.6M options (notional, not included)
Positions72
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.44.9%

Logos Global Management LP reported 72 positions worth $1.65B as of September 30, 2026 (13F filed November 16, 2026). Largest holding: PRAX (6.7%). Biggest move: reduce ERAS ($91.6M).

10 / 72 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 PRAXPraxis Precision Medicines$123.8M6.67%425,000——+6.5%
▸ 2 RVMDRevolution Medicines$123.2M6.63%600,000——-18.7%
▸ 3 IDYAIDEAYA Biosciences$109.5M5.90%2,850,000——-17.2%
▸ 4 ERASErasca$86.5M4.66%5,900,000———
▸ 5 ABVXAbivax S.A.$86.1M4.64%870,000———
▸ 6 CGONCG Oncology$69.1M3.72%975,000——+5.0%
▸ 7 IRONDisc Medicine$66.4M3.58%1,015,000——+17.0%
▸ 8 BNTXBioNTech$63.9M3.44%650,000——-13.3%
▸ 9 TNGXTango Therapeutics$53.6M2.89%2,150,000——-3.1%
▸ 10 MDGLMadrigal Pharmaceuticals$50.4M2.71%100,000——-15.9%

Pro Feature

The remaining 62 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Logos Global Management LP hold as of Q3 2026?

Logos Global Management LP reported 72 positions worth $1.65B in its Q3 2026 13F filing. Largest positions: PRAX (6.7%), RVMD (6.6%), IDYA (5.9%), ERAS (4.7%) and ABVX (4.6%).

What did Logos Global Management LP buy in Q3 2026?

New positions: MDGL, ERAS, NBIX, AXSM and APMD (29 in all). Added to: PRAX, ELVN, GPCR, COGT and AVBP (10 in all).

What did Logos Global Management LP sell in Q3 2026?

Reduced: ERAS, VERA, BNTX, MAZE and DNTH (24 in all). Sold out entirely: CLDX, CMPS, MLYS, REPL and XENE (25 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.